A Metabolome and Microbiome Analysis of Acute Myeloid Leukemia: Insights into the Carnosine-Histidine Metabolic Pathway

Overview

Journal Toxics

Date 2024 Jan 22

PMID 38250970

Authors

Binxiong Wu

Yuntian Xu

Miaomiao Tang

Yingtong Jiang

Ting Zhang

Lei Huang

Shuyang Wang

Yanhui Hu

Kun Zhou

Xiaoling Zhang

Minjian Chen

Affiliations

Soon will be listed here.

Abstract

Metabolism underlies the pathogenesis of acute myeloid leukemia (AML) and can be influenced by gut microbiota. However, the specific metabolic changes in different tissues and the role of gut microbiota in AML remain unclear. In this study, we analyzed the metabolome differences in blood samples from patients with AML and healthy controls using UPLC-Q-Exactive. Additionally, we examined the serum, liver, and fecal metabolome of AML model mice and control mice using UPLC-Q-Exactive. The gut microbiota of the mice were analyzed using 16S rRNA sequencing. Our UPLC-MS analysis revealed significant differences in metabolites between the AML and control groups in multiple tissue samples. Through cross-species validation in humans and animals, as well as reverse validation of Celastrol, we discovered that the Carnosine-Histidine metabolic pathway may play a potential role in the occurrence and progression of AML. Furthermore, our analysis of gut microbiota showed no significant diversity changes, but we observed a significant negative correlation between the key metabolite Carnosine and and . In conclusion, the Carnosine-Histidine metabolic pathway influences the occurrence and progression of AML, while the gut microbiota might play a role in this process.

References

Nair R, Salinas-Illarena A, Baldauf H . New strategies to treat AML: novel insights into AML survival pathways and combination therapies. Leukemia. 2020; 35(2):299-311. DOI: 10.1038/s41375-020-01069-1. View

Paglia G, Del Greco F, Sigurdsson B, Rainer J, Volani C, Hicks A . Influence of collection tubes during quantitative targeted metabolomics studies in human blood samples. Clin Chim Acta. 2018; 486:320-328. DOI: 10.1016/j.cca.2018.08.014. View

Stefaniak J, Nowak M, Wojciechowski M, Milewski S, Skwarecki A . Inhibitors of glucosamine-6-phosphate synthase as potential antimicrobials or antidiabetics - synthesis and properties. J Enzyme Inhib Med Chem. 2022; 37(1):1928-1956. PMC: 9272926. DOI: 10.1080/14756366.2022.2096018. View

Chen S, Zhang L, Li M, Zhang Y, Sun M, Wang L . Fusobacterium nucleatum reduces METTL3-mediated mA modification and contributes to colorectal cancer metastasis. Nat Commun. 2022; 13(1):1248. PMC: 8913623. DOI: 10.1038/s41467-022-28913-5. View

Lam C, Low J, Tran P, Wang H . The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies. Cancer Lett. 2021; 503:11-18. DOI: 10.1016/j.canlet.2021.01.010. View

Stein E, Tallman M . Emerging therapeutic drugs for AML. Blood. 2015; 127(1):71-8. PMC: 4915807. DOI: 10.1182/blood-2015-07-604538. View

Gentile C, Weir T . The gut microbiota at the intersection of diet and human health. Science. 2018; 362(6416):776-780. DOI: 10.1126/science.aau5812. View

Zhou P, Chang W, Gong D, Xia J, Chen W, Huang L . High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate. Cell Metab. 2023; 35(11):1961-1975.e6. DOI: 10.1016/j.cmet.2023.09.009. View

Salvatori S, Marafini I, Laudisi F, Monteleone G, Stolfi C . and Gastric Cancer: Pathogenetic Mechanisms. Int J Mol Sci. 2023; 24(3). PMC: 9917787. DOI: 10.3390/ijms24032895. View

10.

Hakim H, Dallas R, Wolf J, Tang L, Schultz-Cherry S, Darling V . Gut Microbiome Composition Predicts Infection Risk During Chemotherapy in Children With Acute Lymphoblastic Leukemia. Clin Infect Dis. 2018; 67(4):541-548. PMC: 6070042. DOI: 10.1093/cid/ciy153. View

11.

Theilgaard-Monch K . Gut microbiota sustains hematopoiesis. Blood. 2017; 129(6):662-663. DOI: 10.1182/blood-2016-12-754481. View

12.

Ma J, Piao X, Mahfuz S, Long S, Wang J . The interaction among gut microbes, the intestinal barrier and short chain fatty acids. Anim Nutr. 2022; 9:159-174. PMC: 9079705. DOI: 10.1016/j.aninu.2021.09.012. View

13.

Fu M, Zhang X, Liang Y, Lin S, Qian W, Fan S . Alterations in Vaginal Microbiota and Associated Metabolome in Women with Recurrent Implantation Failure. mBio. 2020; 11(3). PMC: 7267891. DOI: 10.1128/mBio.03242-19. View

14.

Li Y, Zhao H, Sun G, Duan Y, Guo Y, Xie L . Alterations in the gut microbiome and metabolome profiles of septic rats treated with aminophylline. J Transl Med. 2022; 20(1):69. PMC: 8812188. DOI: 10.1186/s12967-022-03280-3. View

15.

Li A, Ducker G, Li Y, Seoane J, Xiao Y, Melemenidis S . Metabolic Profiling Reveals a Dependency of Human Metastatic Breast Cancer on Mitochondrial Serine and One-Carbon Unit Metabolism. Mol Cancer Res. 2020; 18(4):599-611. PMC: 7127984. DOI: 10.1158/1541-7786.MCR-19-0606. View

16.

Wang R, Yang X, Liu J, Zhong F, Zhang C, Chen Y . Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate. Nat Commun. 2022; 13(1):2522. PMC: 9085760. DOI: 10.1038/s41467-022-30240-8. View

17.

De Kouchkovsky I, Abdul-Hay M . 'Acute myeloid leukemia: a comprehensive review and 2016 update'. Blood Cancer J. 2016; 6(7):e441. PMC: 5030376. DOI: 10.1038/bcj.2016.50. View

18.

Weersma R, Zhernakova A, Fu J . Interaction between drugs and the gut microbiome. Gut. 2020; 69(8):1510-1519. PMC: 7398478. DOI: 10.1136/gutjnl-2019-320204. View

19.

Yang Q, Zhao J, Hao J, Li B, Huo Y, Han Y . Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia. J Cachexia Sarcopenia Muscle. 2017; 9(1):71-85. PMC: 5803608. DOI: 10.1002/jcsm.12246. View

20.

Yang H, Chen D, Cui Q, Yuan X, Dou Q . Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res. 2006; 66(9):4758-65. DOI: 10.1158/0008-5472.CAN-05-4529. View